Explore All 461 Buyout (LBO, MBO, MBI) Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | April 21, 2022 |
| Target | NuvinkaDx |
| Sector | Life Science |
| Buyer(s) | Ampersand Capital Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| Deal Context for Buyer | # |
|---|---|
| Overall | 70 of 86 |
| Sector: Life Science | 34 of 43 |
| Type: Buyout (LBO, MBO, MBI) | 21 of 23 |
| State: New Hampshire | 2 of 2 |
| Country: United States | 59 of 70 |
| Year: 2022 | 5 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-21 |
ALPCO
Salem, New Hampshire, United States ALPCO is an importer and distributor of immunoassay-based products for the North American life science markets. ALPCO is a provider of proprietary and distributed diagnostics solutions, with over 60 collaborating partners from around the globe. ALPCO was founded in 1990 and is based in Salem, New Hampshire. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-02 |
Vernal Biosciences
Colchester, Vermont, United States Vernal Biosciences provides mRNA and LNP-mRNA manufacturing services to democratize the use of mRNA for all use cases ranging from drug discovery to clinical development across all use cases such as gene editing and regulation, cellular programming, vaccines, mRNA replacement, oncology, autoimmune, and protein degradation. Vernal Biosciences is based in Colchester, Vermont. |
Buy | - |
